It's reported in The Age tonight that a 9 year old boy is in the Monash ICU in Melbourne suffering from a rare respiratory condition called PIMS-TS which is described as being similar to Kawasaki disease and is believed to be linked to COVID-19.
Taking into account that Monash just agreed to participate in the MSB Phase 3 trial it would be interesting to see if consideration is given to offer the young fella a remestemcel-L infusion?
banter and General Discussion, page-1252
-
- There are more pages in this discussion • 9,637 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.5¢ |
Change
-0.025(2.58%) |
Mkt cap ! $1.078B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 94.0¢ | $2.482M | 2.602M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 71720 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 10463 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |